SEC Form 4 · accession 0001171843-16-010659

IMMUNOMEDICS INC · IMMU

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

David M Goldenberg

Officer — CSO & Chairman of the BOD · Director

Period of report

Jun 10, 2016

Accepted (ET)

Jun 14, 2016 · 5:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000722830

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 10, 2016	M	81,990	$2.50	A	2,573,731	D
Common Stock^F1	Jun 10, 2016	M	10,050	$2.63	A	2,583,781	D
Common Stock^F2,F3,F1	Jun 10, 2016	S	92,040	$3.0547	D	2,491,741	D
Common Stock^F4	Jun 10, 2016	M	11,326	$2.63	A	3,320,707	I	See Footnote
Common Stock^F5,F6,F4	Jun 10, 2016	S	11,326	$3.0709	D	3,309,381	I	See Footnote
Common Stock^F1	Jun 13, 2016	M	139,950	$2.63	A	2,631,691	D
Common Stock^F3,F7,F1	Jun 13, 2016	S	139,950	$3.0198	D	2,491,741	D
Common Stock^F4	Jun 13, 2016	M	128,674	$2.63	A	3,438,055	I	See Footnote
Common Stock^F5,F8,F4	Jun 13, 2016	S	128,674	$3.0247	D	3,309,381	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F9	$2.50	Jun 10, 2016	M	81,990	D	—	Jun 10, 2016	Common Stock, par value $0.01 per share	81,990	0	D
Stock Option (right to buy)^F10	$2.63	Jun 10, 2016	M	10,050	D	—	Jun 14, 2016	Common Stock, par value $0.01 per share	10,050	139,950	D
Stock Option (right to buy)^F11,F10	$2.63	Jun 10, 2016	M	11,326	D	—	Jun 14, 2016	Common Stock, par value $0.01 per share	11,326	128,674	I
Stock Option (right to buy)^F10	$2.63	Jun 13, 2016	M	139,950	D	—	Jun 14, 2016	Common Stock, par value $0.01 per share	139,950	0	D
Stock Option (right to buy)^F11,F10	$2.63	Jun 13, 2016	M	128,674	D	—	Jun 14, 2016	Common Stock, par value $0.01 per share	128,674	0	I

Explanation of responses

F1Includes a total of 190,000 shares held as joint tenants by the reporting person and his spouse, Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, the Issuer's President and Chief Executive Officer.
F10These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year.
F11The reporting person's spouse was granted these stock options pursuant to the Issuer's 2002 Stock Incentive Plan.
F2The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.04 to $3.085.
F3The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
F4Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
F5The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
F6The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.07 to $3.08.
F7The price in column 4 is a weighted average price. The prices actually received in this transaction range from $2.96 to $3.12.
F8The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.00 to $3.12.
F9These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.